EAM
BRLI

Eagle Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Eagle Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-79,280
Closed -$2.22M – 666
2014
Q3 		$2.22M Hold
79,280
– – 0.01% 567
2014
Q2 		$2.4M Buy
+79,280
New +$2.19M 0.01% 579

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eagle Asset Management's BRLI Position: Q4 2014 in Review

Eagle Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2014, closing a stake of 79,280 shares — an estimated $2.22M sold.

Eagle Asset Management first reported a position in BRLI in Q2 2014 and held it in 2 quarters. The position peaked at $2.4M in Q2 2014. 182 funds tracked by Wall St. Rank hold BRLI as of Q4 2014.

  • Eagle Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2014 after selling out during the quarter.
  • Eagle Asset Management sold 79,280 BIO-REFERENCE LABS INC-NEW- shares in Q4 2014, an estimated $2.22M.
  • Eagle Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2014 and held it in 2 quarters.
  • Eagle Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $2.4M in Q2 2014.
  • 182 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2014.

Based on Eagle Asset Management's 13F filing for Q4 2014, filed 21 Jan 2015.